Ensayos clínicos de Lupus en Maryland
10 estudios sobre Lupus buscan participantes en Maryland.
Ciudades en Maryland
Texto oficial del estudio (inglés)
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
- Sl0044 50730, Rockville
ReclutandoFase 3
Edades de 16 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT06617325Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Bethesda
ReclutandoEstudio observacional
Edades de 18 a 120 · Mujeres · Actualizado el 28 sept 2026 · NCT05567198A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
- Research Site, Silver Spring
ReclutandoFase 3
Edades de 18 a 70 · Todos los sexos · Actualizado el 25 sept 2026 · NCT07430306Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 23 sept 2026 · NCT03816345The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE) - IFN-CVD
- National Institutes of Health Clinical Center, Bethesda
ReclutandoFase 2
Edades de 18 a 80 · Todos los sexos · Actualizado el 18 sept 2026 · NCT05440422Study of Systemic Lupus Erythematosus
- National Institutes of Health Clinical Center, Bethesda
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 3 a 120 · Todos los sexos · Actualizado el 16 sept 2026 · NCT00001372A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
- Research Site, Baltimore
ReclutandoFase 1/2
Edades de 18 a 70 · Todos los sexos · Actualizado el 10 sept 2026 · NCT06897930A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Johns Hopkins Hospital, Baltimore
ReclutandoFase 1
Edades de 18 a 74 · Todos los sexos · Actualizado el 10 sept 2026 · NCT07085104A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
- Arthritis & Rheumatism Associates, Rockville
ReclutandoEstudio observacional
Edades de 16 en adelante · Todos los sexos · Actualizado el 3 sept 2026 · NCT07175285Double-blind Placebo Controlled Study to Evaluate the Effect of NAD+ Boosting With Nicotinamide Riboside on Immunometabolism and Immunity in Systemic Lupus Erythematosus
- National Institutes of Health Clinical Center, Bethesda
ReclutandoFase 1/2Se aceptan voluntarios sanos
Edades de 18 a 120 · Mujeres · Actualizado el 31 jul 2026 · NCT06032923De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.